Rheumatoid arthritis treated with implanted cells that release drug
The Pharma Data
SEPTEMBER 1, 2021
With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation. Simon Professor of Orthopaedic Surgery.
52 
Let's personalize your content